news

Health - Pharmacology - 16.11.2021

Global study offers new insight on heart valve surgery
By Celine Zadorsky, Special to Western News Researchers at Western and Lawson Health Research Institute played a leading role in a new global study that will change the way surgeons repair leaky valves in the heart. Leaky valve is one of the most common heart conditions, and it often does not present any symptoms. Many patients don't even realize they have a leaky valve, often presenting to doctors only when they are in the late stage of the disease.

Health - Pharmacology - 15.11.2021

New biomarkers for type 1 diabetes
A new study identifies circulating proteins as potential therapeutic targets and screening tools for type 1 diabetes. A research team led by Dr. Despoina Manousaki of the CHU Sainte-Justine Research Centre and the Université de Montréal has identified three circulating proteins as promising molecules for the development of drugs and early detection tools for patients with type 1 diabetes.

Health - Pharmacology - 08.11.2021

COVID-19: The older you are, the more antibodies you have
Université de Montréal chemists looked at lab samples of patients who recovered from a mild case of COVID-19 and found that those over 50 produced more antibodies against the SARS-CoV-2 virus. With the emergence of SARS-CoV-2 variants worldwide, the pandemic's spread is accelerating. A research team led by Joelle Pelletier and Jean-François Masson, both professors in Université de Montréal's Department of Chemistry, wanted to find out whether natural infection or vaccination led to more protective antibodies being generated.

Pharmacology - Health - 01.11.2021

New hope for Duchenne muscular dystrophy patients
Research team at CHU Sainte-Justine has discovered a more effective and less toxic targeted treatment for Duchenne muscular dystrophy. It's called Resolvin-D2. A research team led by Nicolas Dumont, a researcher at CHU Sainte-Justine and professor at the Université de Montréal, has discovered a new therapeutic molecule, Resolvin-D2.

Health - Pharmacology - 25.10.2021

New AI can predict virus mutations and help create more effective treatments and vaccines
New technology can contribute to other medical treatments, such as cancer. Researchers have developed a new method that uses artificial intelligence to foresee the most likely mutations of pathogens like SARS-COV-2, the virus that causes COVID-19. The new research has implications for the rapid development of vaccines, treatments and diagnostic tests that would be much less likely to be impacted by new or emerging variants of concern.

Health - Pharmacology - 05.10.2021

Cancer chemotherapy drug reverses Alzheimer’s symptoms in mice
A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new UBC research has found. The drug, Axitinib, inhibits the growth of new blood vessels in the brain-a feature shared by both cancer tumours and Alzheimer's disease, but this hallmark represents a new target for Alzheimer's therapies.

Health - Pharmacology - 27.09.2021

Discovery of mechanics of drug targets for COVID-19
A team of international researchers, including McGill Professor Stéphane Laporte , have discovered the working mechanism of potential drug targets for various diseases such as cancer, rheumatoid arthritis, and even COVID-19. The findings published in Molecular Cell uncover the inner workings of cell receptors that are involved in cancer progression and inflammatory diseases.

Health - Pharmacology - 23.09.2021

Busting myths about COVID-19 vaccines and fertility
It can be difficult to separate fact from fiction when it comes to COVID-19 vaccines, particularly in relation to fertility and reproductive health. UBC's Dr. Deborah Money, professor in the faculty of medicine's department of obstetrics and gynaecology, busts some of the many myths circulating about the vaccines' impact on fertility.

Health - Pharmacology - 21.09.2021

Access to essential cancer medicines is unequal globally
KINGSTON, ON, September 21, 2021 - Patients in most countries of the world do not have access to basic cancer medicines, according to new research from Queen's University professor Christopher Booth and collaborators at the World Health Organization (WHO). Their paper , published in The Lancet Oncology , asked oncologists worldwide to list the most important cancer medicines and to describe whether patients could access these medicines in their home country.

Pharmacology - Health - 07.09.2021

Chemotherapy drug puts young children with cancer at high risk of hearing loss
75 per cent of patients five years old and younger had experienced cisplatin-related hearing loss three years after starting therapy A chemotherapy drug known to cause hearing loss in children is more likely to do so the earlier in life children receive it, new UBC research has found. Cisplatin is a life-saving treatment for many children with cancer, but the study published today in Cancer shows that the hearing of very young children is impacted early during treatment and is affected to a greater extent than that of older children.

Health - Pharmacology - 17.06.2021

Queen’s researcher develops new blood test for earlier cancer detection and optimization of treatment
A team of researchers at Queen's University, led by Dr. Christopher Mueller (Queen's Cancer Research Institute), have developed a new, cost effective cancer detection and characterization method based on the presence of circulating tumour DNA in the blood called mDETECT (methylation DETEction of Circulating Tumour DNA).

Health - Pharmacology - 28.01.2021

Current cancer research efforts do not match the global burden of the disease
January 28 - A new study involving scientists at Queen's University has found that current cancer research efforts do not match the global burden of deaths from the disease. The research was led by Christopher Booth, Professor of Oncology and Public Health Sciences and Canada Research Chair in Population Cancer Care.